BR112015019748A2 - Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270 - Google Patents

Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270

Info

Publication number
BR112015019748A2
BR112015019748A2 BR112015019748A BR112015019748A BR112015019748A2 BR 112015019748 A2 BR112015019748 A2 BR 112015019748A2 BR 112015019748 A BR112015019748 A BR 112015019748A BR 112015019748 A BR112015019748 A BR 112015019748A BR 112015019748 A2 BR112015019748 A2 BR 112015019748A2
Authority
BR
Brazil
Prior art keywords
cncm
streptococcus thermophilus
obesity
treatment
oxidative stress
Prior art date
Application number
BR112015019748A
Other languages
English (en)
Inventor
Montserrat Carreras Agusti
Alvarez Fernández Cristina
Andreu Corominas Montserrat
Ramon Vidal Daniel
Bataller Leiva Esther
Martorell Guerola Patricia
Genovés Martínez Salvador
Original Assignee
Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danone Sa filed Critical Danone Sa
Publication of BR112015019748A2 publication Critical patent/BR112015019748A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PEPTÍDEO TENDO ATIVIDADE INIBITÓRIA DA PL E/OU PLA2, PRODUTO ALIMENTÍCIO ADEQUADO PARA O TRATAMENTO DA OBESIDADE E/OU ESTRESSE OXIDATIVO, E, USO DE STREPTOCOCCUS THERMOPHILUS CNCM I-2776 E/OU STREPTOCOCCUS THERMOPHILUS CNCM I-1630 E/OU LACTOBACILLUS PARACASEI SUBSP PARACASEI CNCM I-4270. A presente invenção refere-se a certos peptídeos obteníveis por meio da hidrólise a partir da glicina de soja por meio da ação das culturas sobrenadantes das cepas pertencentes ao gênero Lactobacillus ou Streptococcus. Estes peptídeos, extratos contendo-os e produtos alimentícios contendo-os são úteis para o tratamento e/ou prevenção da obesidade e estresse oxidativo.
BR112015019748A 2013-02-19 2013-02-19 Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270 BR112015019748A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/053233 WO2014127798A1 (en) 2013-02-19 2013-02-19 Functional peptides for obesity disorders

Publications (1)

Publication Number Publication Date
BR112015019748A2 true BR112015019748A2 (pt) 2017-08-22

Family

ID=47722294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015019748A BR112015019748A2 (pt) 2013-02-19 2013-02-19 Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270

Country Status (10)

Country Link
US (1) US9802990B2 (pt)
EP (1) EP2958578B1 (pt)
JP (1) JP2016508510A (pt)
CN (1) CN105163748B (pt)
BR (1) BR112015019748A2 (pt)
CA (1) CA2897742A1 (pt)
ES (1) ES2676436T3 (pt)
MX (1) MX2015010694A (pt)
RU (1) RU2015132368A (pt)
WO (1) WO2014127798A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114835784A (zh) * 2015-07-16 2022-08-02 努里塔斯有限公司 抗炎肽及其用途
WO2017010133A1 (ja) * 2015-07-16 2017-01-19 サントリーホールディングス株式会社 動植物由来ペプチド含有血清カルノシン分解酵素阻害用組成物
SG11201804647TA (en) 2015-12-04 2018-06-28 Global Blood Therapeutics Inc Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
KR101887576B1 (ko) * 2016-04-15 2018-08-13 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
CN116491631A (zh) * 2023-05-26 2023-07-28 青岛农业大学 一种预制菜红烧肉及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2960947B2 (ja) 1989-12-25 1999-10-12 日清製粉株式会社 脂質分解酵素阻害剤
EP1529114A1 (en) * 2002-08-09 2005-05-11 Chr. Hansen A/S Process for preparing peptides with anti-hypertensive properties
JP2004099447A (ja) * 2002-09-04 2004-04-02 Kyowa Hakko Kogyo Co Ltd コレステロール低減化ペプチド
US20060204617A1 (en) * 2003-08-08 2006-09-14 Astrid Hauser Fermented food product comprising soy protein
FR2876876B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
US9034402B2 (en) 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
FR2929511B1 (fr) * 2008-04-02 2010-12-31 Basf Beauty Care Solutions France Sas Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.
EP2545160B1 (en) * 2010-03-12 2018-07-18 Compagnie Gervais Danone Lactic acid bacteria for coeliac disease
JP2012116817A (ja) * 2010-12-03 2012-06-21 Fuji Oil Co Ltd 蛋白質組成物の加水分解物を含有する抗酸化剤
JP5686680B2 (ja) * 2011-06-24 2015-03-18 カルピス株式会社 乳酸菌発酵によるカゼイン由来ペプチドの製造方法

Also Published As

Publication number Publication date
WO2014127798A1 (en) 2014-08-28
US9802990B2 (en) 2017-10-31
CN105163748A (zh) 2015-12-16
US20160002303A1 (en) 2016-01-07
CA2897742A1 (en) 2014-08-28
MX2015010694A (es) 2016-04-25
RU2015132368A (ru) 2017-03-27
EP2958578A1 (en) 2015-12-30
CN105163748B (zh) 2017-11-21
JP2016508510A (ja) 2016-03-22
EP2958578B1 (en) 2018-04-11
ES2676436T3 (es) 2018-07-19

Similar Documents

Publication Publication Date Title
BR112015019748A2 (pt) Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270
PH12018500566A1 (en) Novel lactobacillus having various functions, and use thereof
NZ777234A (en) Compositions comprising bacterial strains
BR112018077266A2 (pt) composições compreendendo cepas bacterianas
UA113059C2 (xx) Протимікробна композиція на основі штамів lactobacillus rhamnosus, lactobacillus paracasei
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
BR112015025256A8 (pt) Cepas probióticas para uso no tratamento ou prevenção da osteoporose
MX2015000338A (es) Novedosa cepa de lactobacillus crispatus.
IT201600091033A1 (it) Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
BR112019001116A2 (pt) composição probiótica usada no tratamento e/ou prevenção da dermatite atópica
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
RS54837B1 (sr) Upotreba streptococcus salivarius u lečenju hroničnih infekcija respiratornog trakta
RU2012102851A (ru) Штамм enterococcus durans вкпм в-8731, используемый для производства кисломолочных продуктов и пробиотических препаратов
BR112018070518A2 (pt) bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura
MX2018007780A (es) Composiciones y metodos de uso de cepas novedosas de lactobacillus fermentum.
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
TR201808116T1 (tr) İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
MX350212B (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.
MX2018012312A (es) Lactobacillus rhamnosus para su uso en la preparacion de productos fermentados.
WO2019054641A3 (ko) 락토바실러스 플란타룸을 포함하는 위장관 질환의 예방 및 개선용 조성물
CO2020009424A2 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]